BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
Public ClinicalTrials.gov record NCT02220790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to 1) define the operating characteristics of fungal biomarker assays in pediatric patients at high-risk for developing invasive candidiasis, 2) determine the change in fungal biomarker assay results in children who develop invasive candidiasis, and 3) create a biobank of blood samples from pediatric patients at high-risk for invasive candidiasis and those with invasive candidiasis for future testing of fungal biomarker assays and development of new fungal biomarker assays. The study will assemble a prospective cohort of pediatric patients at high-risk for developing invasive candidiasis. Blood samples for biomarker testing will be obtained at the time a patient has a clinical indication for blood culture attainment. Additional blood sampling will be performed on the sub-set of patients that are found to have invasive candidiasis. The sensitivity, specificity, PPV, and NPV of biomarker assays will be determined for each biomarker assay. No PHI will be stored in the database and limits on blood draws (3 ml/kg in an 8 week period) will be adhered to.
Study identification
- NCT ID
- NCT02220790
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 515 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 120 Days to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2015 (Type not available)
- Primary completion
- Oct 8, 2020 (Actual)
- Completion
- Oct 8, 2020 (Actual)
- Last update posted
- Feb 28, 2022
2015 – 2020
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | — | — |
| Children's Hospital of Orange County | Orange | California | — | — |
| Rady Children's Hospital | San Diego | California | — | — |
| UCSF Benioff Children's Hospital | San Francisco | California | — | — |
| All Children's Hospital | St. Petersburg | Florida | — | — |
| Ann and Robert Lurie Children's Hospital of Chicago | Chicago | Illinois | — | — |
| Boston Children's Hospital | Boston | Massachusetts | — | — |
| Children's Mercy | Kansas City | Missouri | — | — |
| Cohen Children's Medical Center of New York | New Hyde Park | New York | — | — |
| New York-Presbyterian Phyllis and David Komansky Center for Children's Health | New York | New York | — | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Cincinnati Children's Medical Center | Cincinnati | Ohio | — | — |
| Cleveland Clinic Children's | Cleveland | Ohio | — | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | — | — |
| Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | — | — |
| St Jude Children's Research Hospital | Memphis | Tennessee | — | — |
| Dell Children's Medical Center | Austin | Texas | — | — |
| Texas Children's Hospital | Houston | Texas | — | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02220790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02220790 live on ClinicalTrials.gov.